| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.11B | 10.67B | 9.58B | 8.12B | 8.99B | 6.84B |
| Gross Profit | 2.45B | 2.65B | 2.48B | 2.76B | 2.43B | 1.89B |
| EBITDA | 1.08B | 1.35B | 1.25B | 1.76B | 1.59B | 985.09M |
| Net Income | 108.79M | 452.69M | 708.76M | 812.06M | 654.06M | 304.06M |
Balance Sheet | ||||||
| Total Assets | 21.56B | 21.20B | 19.31B | 17.35B | 16.37B | 15.70B |
| Cash, Cash Equivalents and Short-Term Investments | 3.19B | 3.29B | 3.60B | 2.83B | 2.37B | 2.02B |
| Total Debt | 10.28B | 10.10B | 8.62B | 8.90B | 8.58B | 9.04B |
| Total Liabilities | 12.32B | 11.96B | 10.72B | 10.49B | 10.40B | 10.38B |
| Stockholders Equity | 9.15B | 9.14B | 8.49B | 6.79B | 5.89B | 5.29B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.44B | 584.36M | 826.37M | 1.25B | -1.43B |
| Operating Cash Flow | 0.00 | 21.92M | 1.66B | 1.99B | 2.41B | 297.16M |
| Investing Cash Flow | 0.00 | -1.60B | -1.58B | -1.77B | -1.48B | -2.16B |
| Financing Cash Flow | 0.00 | 1.27B | 638.92M | 240.73M | -534.92M | 928.54M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥10.63B | 6.23 | ― | 2.33% | -6.09% | 24.42% | |
69 Neutral | ¥15.35B | 6.15 | ― | 3.79% | -0.03% | 84.08% | |
67 Neutral | ¥20.96B | 9.63 | ― | 3.27% | 7.63% | 11.84% | |
65 Neutral | ¥12.79B | 8.30 | ― | 2.63% | 18.27% | -4.07% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥6.61B | -34.26 | ― | ― | 24.34% | 80.81% | |
55 Neutral | ¥6.66B | -1.99 | ― | 1.54% | 3.37% | -27.47% |